Post by Monte Rosa Therapeutics
34,841 followers
Georg Petzold and Chao Q. recently sat down with Endpoints News Webinars for a discussion on the surprising versatility of molecular glue degraders. They delve into emerging insights around cereblon biology, target engagement, and the broader potential of MGDs to help unlock previously undruggable targets and new therapeutic opportunities. View the webinar here: https://bit.ly/4ugCDDV
Video Content